tiprankstipranks
MAIA Biotechnology Boosts CEO Jeffrey Himmelreich’s Salary
Company Announcements

MAIA Biotechnology Boosts CEO Jeffrey Himmelreich’s Salary

Pick the best stocks and maximize your portfolio:

MAIA Biotechnology, Inc. (MAIA) just unveiled an announcement.

Starting April 1, 2024, Jeffrey Himmelreich’s employment agreement will see his base salary raised to $250,000, with his target annual bonus climbing to 25% of his base salary, reflecting a substantial increase in his compensation package.

Find detailed analytics on MAIA stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyMAIA Biotechnology granted FDA rare pediatric disease designation for THIO
TheFlyMAIA Biotechnology to sell 507,364 shares at $1.872 in private placement
TheFlyMAIA Biotechnology, Regeneron expand clinical supply agreement
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App